.png){kind=small}
.png){kind=small}
BackTable / Urology / Podcast / Episode #209
Management of Bladder Cancer: Insights from Community Practice
with Dr. Gautam Jayram
Are you a private practice urologist looking to build your bladder cancer service lines? In this episode of the BackTable Urology Podcast, Dr. Tom Jayram, urologist from Nashville joins host Dr. Aditya Bagrodia to discuss the latest advancements in non-muscle invasive bladder cancer treatment. The conversation focuses on the unique experiences and practical considerations in managing this complex condition in the community setting.
This podcast is supported by:
Be part of the conversation. Put your sponsored messaging on this episode. Learn how.
BackTable, LLC (Producer). (2025, January 14). Ep. 209 – Management of Bladder Cancer: Insights from Community Practice [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Podcast Contributors
Synopsis
The two urologic oncologists share their decision-making process for different therapies such as BCG, gemcitabine-doxorubicin, and Adstiladrin. The conversation also touches on the challenges of integrating new technologies into practice, managing the BCG shortage, and the role of multidisciplinary care. They discuss patient-centered care and the potential for personalized treatment plans. Finally, Dr. Jayram reflects on the lessons he has learned from his own practice, offering a unique insight into the differences between academic and community urology.
Timestamps
00:00 - Introduction
04:47 - Community Practice and New Technologies
09:59 - Clinical Trials for Bladder Cancer Care
15:52 - Patient Referrals
29:27 - Exploring New Treatment Options
30:46 - Bladder Sparing Strategies
32:21 - BCG Treatment and Surveillance
47:04 - Implementation of New Therapies
54:27 - Future Directions
Resources
Ferring Pharmaceuticals
https://www.ferring.com/
Transcript Preview
You go to the doctor, you've had BPH, and, "Okay. Mr. Smith, how are you doing?" "Oh, I'm doing fine, doctor." Come to find out, you've had him on Flomax for 10 years, and he's up four times a night, and he's bathroom hunting everywhere he's outside, and he's not happy.
He's not comfortable telling you in every situation that, "Hey, this is failing for me." "What is failing? Is this okay? Is this just me getting old? Am I expected? Everyone says when you get old, this happens. I guess this is just part of aging, so I'll just live with it." I think that IPSS Score was somewhat liberating for patients to write down what they're really dealing with. Whether they felt like that was good or bad was not really the point.
The Materials available on BackTable are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.
Up Next
Articles
Topics
